欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2008, Vol. 13 ›› Issue (3): 340-343.

• 药物治疗学 • 上一篇    下一篇

氯诺昔康与布托啡诺用于腹腔镜胆囊切除术后镇痛效果

喻君1, 郭建荣1, 金孝岠2   

  1. 1浙江省宁波市宁波大学附属李惠利医院麻醉科, 宁波315040, 浙江;
    2安徽省芜湖市皖南医学院附属弋矶山医院麻醉科, 芜湖241001, 安徽
  • 收稿日期:2007-09-30 修回日期:2007-09-30 发布日期:2020-10-15
  • 作者简介:喻君, 女, 在读硕士, 研究方向:麻醉与应激。郭建荣, 男, 博士后, 硕士生导师, 教授, 研究方向:麻醉生理与药理学研究。Tel:13867854398 E-mail:guomzk @yahoo.com.cn

Effects of postoperative analgesia with lornoxicam and butorphano in patients undergoing laparoscopic cholecystectomy

YU Jun1, GUO Jian-rong1, JIN Xiao-ju2   

  1. 1Department of Anesthesiology, Affiliated Lihuili Hospital, Ningbo University, Ningbo 315040, Zhejiang, China;
    2Department of Anesthesiology, Affiliated Yijishan Hospital, Wannan Medical College, Wuhu 241001, Anhui, China
  • Received:2007-09-30 Revised:2007-09-30 Published:2020-10-15

摘要: 目的 对比观察氯诺昔康和布托啡诺用于腹腔镜胆囊切除术(LC) 后镇痛的临床效果。 方法 90 例ASA Ⅰ ~ Ⅱ级择期在全麻下行腹腔镜胆囊切除术的患者, 随机分为氯诺昔康、布托啡诺和生理盐水3 组, 每组30 例。各组患者于术毕伤口疼痛时, 分别静注氯诺昔康8 mg 、布托啡诺1 mg和生理盐水2 mL, 观察并记录各组注药后1 、6 、12 、24 h 的疼痛视觉模拟评分(VAS 值) 、镇静评分、舒适评分、生命体征的变化和不良反应的发生情况。 结果 氯诺昔康、布托啡诺组术后各时点VAS 评分、镇静评分、舒适评分与生理盐水组比较差异有统计学意义(P <0.01), 术后镇痛期间生命体征变化组间比较差异无统计学意义(P >0.05), 氯诺昔康组术后恶心、呕吐发生率低于生理盐水组(P <0.05), 注药后1 h 布托啡诺组头晕和嗜睡的发生率明显高于氯诺昔康组(P <0.05) 。 结论 氯诺昔康和布托啡诺对LC 患者均具有良好的术后镇痛效果, 术后不良反应发生率低。

关键词: 氯诺昔康, 布托啡诺, 术后镇痛, 腹腔镜胆囊切除

Abstract: AIM: To investigate the effect of postoperative analgesia with Lornoxicam and butorphano after laparoscopic cholecystectomy (LC). METHODS: 90 ASA Ⅰ-Ⅱpatients scheduled for LC were randomly divided into three groups:group lornoxicam (n = 30) received lornoxicam 8 mg, group butorphano (n = 30) received butorphano 1mg, group NS (n =30) received 0.9%NS 2 mL at the time of the complaint of pain by the patients after extubate of tracheal catheter. Postoperative abdomen pain was assessed by visual analog scale (VAS), the patients were assessed by brungmann comfort scale (BCS) and Ramesay score (RS) within 1, 6, 12, 24 hours postoperatively.Side-effects were also assessed. RESULTS: The patients of group lornoxicam and butorphano had significantly higher BCS and RS scores than group NS (P <0.01), both of them also had significantly lower VAS than group NS (P <0.01).Group lornoxicam caused no more sideeffect, such as nausea, vomiting than group butorphano and NS(P <0.05). CONCLUSION: The study suggests that postoperative analgesia with lornoxicam 8 mg or butorphano 1 mg provide satisfactory postoperative pain relief with no more side-effects for patients undergoing LC.

Key words: lornoxicam, butorphano, postoperative analgesia, laparoscopic cholecystectomy

中图分类号: